Limit search to available items
Result Page   
Add Marked to Bag Add All On Page Add Marked to My Lists
Num Mark Authors (Last name first) (1-50 of 984) Year Entries
1810 Found
1   Institute of Medicine (U.S.) -- 3 Related Authors (Last Name First)   3
2 Institute of Medicine (U.S.)   163
3 Institute of Medicine (U.S.). Advisory Panel for the Study of Long-Term Health Effects of Participation in Project SHAD. / http://id.loc.gov/authorities/names/no2007120119  2007 1
4  

Institute of Medicine (U.S.). American Society of Clinical Oncology and Institute of Medicine Workshop -- See American Society of Clinical Oncology and Institute of Medicine Workshop


  1
5  

Institute of Medicine (U.S.). Board of Health Care Services -- See Institute of Medicine (U.S.). Board on Health Care Services


  1
6  

Institute of Medicine (U.S.). Board of Health Promotion and Disease Prevention. Committee on Identifying Effective Treatments for Gulf War Veterans' Health Problems -- See Institute of Medicine (U.S.). Committee on Identifying Effective Treatments for Gulf War Veterans' Health Problems


  1
7  

Institute of Medicine (U.S.). Board of Population Health and Public Health Practice. Committee on the State of the USA Health Indicators -- See Institute of Medicine (U.S.). Committee on the State of the USA Health Indicators


  1
8 Institute of Medicine (U.S.). Board on Biobehavioral Sciences and Mental Disorders   1996 1
9  

Institute of Medicine (U.S.). Board on Children, Youth, and Families -- See National Research Council (U.S.). Board on Children, Youth, and Families


  1
10  

Institute of Medicine (U.S.). Board on Children, Youth, and Families. Committee to Evaluate the Supplemental Security Income Disability Program for Children with Mental Disorders -- See Institute of Medicine (U.S.). Committee to Evaluate the Supplemental Security Income Disability Program for Children with Mental Disorders


  1
11   Institute of Medicine (U.S.). Board on Global Health -- 2 Related Authors (Last Name First)   2
12 Institute of Medicine (U.S.). Board on Global Health.   25
13  

Institute of Medicine (U.S.). Board on Global Health. Committee for the Assessment of DoD-GEIS Influenza Surveillance and Response Programs -- See Institute of Medicine (U.S.). Committee for the Assessment of DoD-GEIS Influenza Surveillance and Response Programs


  1
14  

Institute of Medicine (U.S.). Board on Global Health. Committee for the Evaluation of the President's Emergency Plan for AIDS Relief (PEPFAR) Implementation -- See Institute of Medicine (U.S.). Committee for the Evaluation of the President's Emergency Plan for AIDS Relief (PEPFAR) Implementation


  1
15  

Institute of Medicine (U.S.). Board on Global Health. Committee on Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin -- See Institute of Medicine (U.S.). Committee on Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin


  1
16  

Institute of Medicine (U.S.). Board on Global Health. Committee on Cancer Control in Low- and Middle-Income Countries -- See Institute of Medicine (U.S.). Committee on Cancer Control in Low- and Middle-Income Countries


  1
17  

Institute of Medicine (U.S.). Board on Global Health. Committee on Emerging Microbial Threats to Health in the 21st Century -- See Institute of Medicine (U.S.). Committee on Emerging Microbial Threats to Health in the 21st Century


  1
18  

Institute of Medicine (U.S.). Board on Global Health. Committee on Envisioning a Strategy to Prepare for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests -- See Institute of Medicine (U.S.). Committee on Envisioning a Strategy to Prepare for the Long-Term Burden of HIV/AIDS: African Needs and U.S. Interests


  1
19  

Institute of Medicine (U.S.). Board on Global Health. Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings -- See Institute of Medicine (U.S.). Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings


  1
20   Institute of Medicine (U.S.). Board on Global Health. Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase III -- 2 Related Authors (Last Name First)   2
21  

Institute of Medicine (U.S.). Board on Global Health. Committee on Improving Birth Outcomes -- See Institute of Medicine (U.S.). Committee on Improving Birth Outcomes


  1
22  

Institute of Medicine (U.S.). Board on Global Health. Committee on Investing in Health Systems in Low- and Middle-Income Countries -- See Institute of Medicine (U.S.). Committee on Investing in Health Systems in Low- and Middle-Income Countries


  1
23  

Institute of Medicine (U.S.). Board on Global Health. Committee on Measures to Enhance the Effectiveness of the CDC Quarantine Station Expansion Plan for U.S. Ports of Entry -- See Institute of Medicine (U.S.). Committee on Measures to Enhance the Effectiveness of the CDC Quarantine Station Expansion Plan for U.S. Ports of Entry


  1
24  

Institute of Medicine (U.S.). Board on Global Health. Committee On Measuring The Impact Of Interprofessional Education On Collaborative Practice and Patient Outcomes -- See Institute of Medicine (U.S.). Committee On Measuring The Impact Of Interprofessional Education On Collaborative Practice and Patient Outcomes


  1
25  

Institute of Medicine (U.S.). Board on Global Health. Committee on Nervous System Disorders in Developing Countries -- See Institute of Medicine (U.S.). Committee on Nervous System Disorders in Developing Countries


  1
26  

Institute of Medicine (U.S.). Board on Global Health. Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries -- See Institute of Medicine (U.S.). Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries


  1
27  

Institute of Medicine (U.S.). Board on Global Health. Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries -- See Institute of Medicine (U.S.). Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries


  1
28  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Assessment of Future Scientific Needs for Live Variola Virus -- See Institute of Medicine (U.S.). Committee on the Assessment of Future Scientific Needs for Live Variola Virus


  1
29  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Economics of Antimalarial Drugs -- See Institute of Medicine (U.S.). Committee on the Economics of Antimalarial Drugs


  1
30  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Methodological Challenges in HIV Prevention Trials -- See Institute of Medicine (U.S.). Committee on the Methodological Challenges in HIV Prevention Trials


  1
31  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Options for Overseas Placement of U.S. Health Professionals -- See Institute of Medicine (U.S.). Committee on the Options for Overseas Placement of U.S. Health Professionals


  1
32  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Outcome and Impact Evaluation of Global HIV/AIDS Programs Implemented under the Lantos-Hyde Act of 2008 -- See Institute of Medicine (U.S.). Committee on the Outcome and Impact Evaluation of Global HIV/AIDS Programs Implemented under the Lantos-Hyde Act of 2008


  1
33  

Institute of Medicine (U.S.). Board on Global Health. Committee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries -- See Institute of Medicine (U.S.). Committee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries


  1
34  

Institute of Medicine (U.S.). Board on Global Health. Committee on the U.S. Commitment to Global Health -- See Institute of Medicine (U.S.). Committee on the U.S. Commitment to Global Health


  1
35  

Institute of Medicine (U.S.). Board on Global Health. Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products -- See Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products


  1
36  

Institute of Medicine (U.S.). Board on Global Health. Forum on Emerging Infections -- See Institute of Medicine (U.S.). Forum on Emerging Infections


  1
37  

Institute of Medicine (U.S.). Board on Global Health. Forum on Global Violence Prevention -- See Institute of Medicine (U.S.). Forum on Global Violence Prevention


  1
38  

Institute of Medicine (U.S.). Board on Health Care Services -- See Also Panel on Measuring Medical Care Risk in Conjunction with the New Supplemental Income Poverty Measure


  1
39 Institute of Medicine (U.S.). Board on Health Care Services.   26
40  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Breast Cancer and the Environment: The Scientific Evidence, Research Methodology, and Future Directions -- See Institute of Medicine (U.S.). Committee on Breast Cancer and the Environment: The Scientific Evidence, Research Methodology, and Future Directions


  1
41  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders -- See Institute of Medicine (U.S.). Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders


  1
42  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Data Standards for Patient Safety -- See Institute of Medicine (U.S.). Committee on Data Standards for Patient Safety


  1
43  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Defining and Revising an Essential Health Benefits Package for Qualified Health Plans -- See Institute of Medicine (U.S.). Committee on Defining and Revising an Essential Health Benefits Package for Qualified Health Plans


  1
44  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Diagnostic Error in Health Care -- See Institute of Medicine (U.S.). Committee on Diagnostic Error in Health Care


  1
45  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Geographic Adjustment Factors in Medicare Payment -- See Institute of Medicine (U.S.). Committee on Geographic Adjustment Factors in Medicare Payment


  1
46  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care -- See Institute of Medicine (U.S.). Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care


  1
47  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Health Insurance Status and Its Consequences -- See Institute of Medicine (U.S.). Committee on Health Insurance Status and Its Consequences


  1
48  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Identifying and Preventing Medication Errors -- See Institute of Medicine (U.S.). Committee on Identifying and Preventing Medication Errors


  1
49  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Identifying Priority Areas for Quality Improvement -- See Institute of Medicine (U.S.). Committee on Identifying Priority Areas for Quality Improvement


  1
50  

Institute of Medicine (U.S.). Board on Health Care Services. Committee on Medicare Coverage of Routine Thyroid Screening -- See Institute of Medicine (U.S.). Committee on Medicare Coverage of Routine Thyroid Screening


  1
Add Marked to Bag Add All On Page
Locate in results
Result Page